Edwards Lifesciences Corporation
Edwards Lifesciences Corporation（EW）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · EW · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
43
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Edwards Lifesciences Corporation内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
EW 季度内部人买卖趋势
EW 内幕交易卖出 · EW 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · EW CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
EW 高管卖出股份 · EW 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 29, 2026 | Dahl Andrew M. SVP, Corporate Controller | Sale | 567.527 | $49K | Form 4 |
| May 27, 2026 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale | 23,145 | $2.00M⚡ | Form 4 |
| May 22, 2026 | Chopra Daveen CVP, TMTT & Surgical | Sale | 1,500 | $127K | Form 4 |
| May 18, 2026 | Lippis Daniel J. CVP, TAVR | Option | 620 | $45K | Form 4 |
| May 18, 2026 | Lippis Daniel J. CVP, TAVR | Sale | 620 | $50K | Form 4 |
| May 15, 2026 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale | 8,000 | $655K | Form 4 |
| May 15, 2026 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale | 9,968 | $818K | Form 4 |
| May 11, 2026 | Zovighian Bernard J CEO · Director | Option | 47,207 | — | Form 4 |
| May 11, 2026 | Zovighian Bernard J CEO · Director | Other | 26,198 | $2.09M⚡ | Form 4 |
| May 12, 2026 | Zovighian Bernard J CEO · Director | Gift | 26,640 | — | Form 4 |
| May 12, 2026 | Zovighian Bernard J CEO · Director | Gift | 26,640 | — | Form 4 |
| May 12, 2026 | Zovighian Bernard J CEO · Director | Sale | 845 | $66K | Form 4 |
| May 12, 2026 | Zovighian Bernard J CEO · Director | Sale | 35,506 | $2.77M⚡ | Form 4 |
| May 11, 2026 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option | 13,457 | — | Form 4 |
| May 11, 2026 | BOBO DONALD E JR CVP,Strategy/Corp Development | Other | 7,469 | $597K | Form 4 |
| May 11, 2026 | Chopra Daveen CVP, TMTT & Surgical | Option | 13,583 | — | Form 4 |
| May 11, 2026 | Chopra Daveen CVP, TMTT & Surgical | Other | 7,538 | $603K | Form 4 |
| May 11, 2026 | Ullem Scott B. CVP, Chief Financial Officer | Option | 19,830 | — | Form 4 |
| May 11, 2026 | Ullem Scott B. CVP, Chief Financial Officer | Other | 11,004 | $880K | Form 4 |
| May 7, 2026 | Markowitz Wayne CVP, JAPAC | Award | 5,200 | — | Form 4 |
| May 7, 2026 | Markowitz Wayne CVP, JAPAC | Other | 264 | $22K | Form 4 |
| May 8, 2026 | Markowitz Wayne CVP, JAPAC | Other | 226 | $19K | Form 4 |
| May 11, 2026 | Markowitz Wayne CVP, JAPAC | Sale | 593 | $47K | Form 4 |
| May 7, 2026 | Zovighian Bernard J CEO · Director | Award | 43,800 | — | Form 4 |
| May 7, 2026 | Zovighian Bernard J CEO · Director | Other | 4,153 | $346K | Form 4 |
BOBO DONALD E JR
CVP,Strategy/Corp Development
日期
May 27
股数
23,145
均价
$86.42
总金额
$2.00M ⚡
BOBO DONALD E JR
CVP,Strategy/Corp Development
日期
May 15
股数
8,000
均价
$81.82
总金额
$655K
BOBO DONALD E JR
CVP,Strategy/Corp Development
日期
May 15
股数
9,968
均价
$82.07
总金额
$818K
BOBO DONALD E JR
CVP,Strategy/Corp Development
日期
May 11
股数
7,469
均价
$79.96
总金额
$597K
Ullem Scott B.
CVP, Chief Financial Officer
日期
May 11
股数
11,004
均价
$79.96
总金额
$880K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 EW 内幕交易
EW 内幕交易
Edwards Lifesciences Corporation（EW）内幕交易数据来源于公司内部人（包括Zovighian Bernard J (CEO · Director), Lippis Daniel J. (CVP, TAVR), Ullem Scott B. (CVP, Chief Financial Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。EW内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Edwards Lifesciences Corporation机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
EW 内幕交易 · 5个问题Edwards Lifesciences Corporation（EW）的内部人包括高管和董事，如Zovighian Bernard J (CEO · Director), Lippis Daniel J. (CVP, TAVR), Ullem Scott B. (CVP, Chief Financial Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026